The effect of 2,3-dihydroxybenzoic acid and tempol in prevention of vancomycin-induced nephrotoxicity in rats.
One of the major adverse effects of vancomycin (VAN) is nephrotoxicity, which the mechanism is not fully understood. However, there is some evidence that oxidative injury could be involved in its pathogenesis. In this study, we examined two antioxidants 4-hydroxyl-2,2,6,6-tetramethylpiperidine-1-oxyl (tempol) a superoxide dismutase mimetic and 2,3-dihydroxybenzoic acid (DHB) an iron chelator in VAN-induced nephrotoxicity in rats. DHB at doses of 50 and 100 mg/kg and tempol at doses of 7.5, 15 and 30 mg/kg were administered subcutaneously to rats 30 min prior to intraperitoneal injection of 200 mg/kg VAN. Drug administrations were done every 12 h for 7 days. In animals which received only VAN, the activity of urinary gamma-glutamyl-transferase (GGT) decreased and the activity of lactate dehydrogenase (LDH) in urine increased significantly compared to controls. Serum urea and creatinine (Cr) concentrations and the weight of animals' kidneys increased and body weights were decreased significantly in this group compared to controls. DHB at both doses normalized the GGT activity, but only at the higher dose restore the LDH activity. Both doses of DHB ameliorated the rise in serum urea and Cr concentrations and improved the changes in kidney and body weights significantly. Tempol did not show any beneficial effects at all. There were marked pathologic changes in tubules of kidneys of VAN treated animals. The tissue injury was prevented by both doses of DHB and there was almost no sign of tubular injury in 100 mg/kg treated group. Tempol in any doses could not prevent the tissue injury and there were significant differences in tissue injury in all tempol treated rats with controls. It seems that VAN-induced nephrotoxicity is at least partly due to free radical formation. Hydroxyl radicals might play a major role in VAN-induced nephrotoxicity, since an iron chelator (DHB) could reverse the adverse effects. However, production of other radicals such as superoxide is also probable.
Naghibi
Bijan
B
Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Hezar Jarib Ave., Isfahan, Iran. Naghibi1@excite.com
Ghafghazi
Taghi
T
Hajhashemi
Valiollah
V
Talebi
Ardeshir
A
Taheri
Diana
D
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D018826:CD13 Antigens / Q000652:urine; D003404:Creatinine / Q000097:blood; D003497:Cyclic N-Oxides / Q000494:pharmacology*; D004347:Drug Interactions; D006651:Histocytochemistry; D062385:Hydroxybenzoates / Q000494:pharmacology*; D007502:Iron Chelating Agents / Q000494:pharmacology*; D007674:Kidney Diseases / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D007770:L-Lactate Dehydrogenase / Q000652:urine; D008297:Male; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D013113:Spin Labels; D014508:Urea / Q000097:blood; D014640:Vancomycin / Q000037:antagonists & inhibitors / Q000633:toxicity*; D005723:gamma-Glutamyltransferase / Q000652:urine
D000975:Antioxidants; D003497:Cyclic N-Oxides; D062385:Hydroxybenzoates; D007502:Iron Chelating Agents; D013113:Spin Labels; D014640:Vancomycin; C009135:2,3-dihydroxybenzoic acid; D014508:Urea; D003404:Creatinine; D007770:L-Lactate Dehydrogenase; D005723:gamma-Glutamyltransferase; D018826:CD13 Antigens; C001803:tempol